N-acetylcholinesterase-induced apoptosis in Alzheimer's disease.
<h4>Background</h4>Alzheimer's disease (AD) involves loss of cholinergic neurons and Tau protein hyper-phosphorylation. Here, we report that overexpression of an N-terminally extended "synaptic" acetylcholinesterase variant, N-AChE-S is causally involved in both these phen...
Guardado en:
Autores principales: | Debra Toiber, Amit Berson, David Greenberg, Naomi Melamed-Book, Sophia Diamant, Hermona Soreq |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2018499a57c049bf8580dad94ba61bb7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Activation of the alternative NFκB pathway improves disease symptoms in a model of Sjogren's syndrome.
por: Adi Gilboa-Geffen, et al.
Publicado: (2011) -
Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors
por: Ferris SH, et al.
Publicado: (2013) -
Efficacy of Acetylcholinesterase Inhibitors on Cognitive Function in Alzheimer’s Disease. Review of Reviews
por: Marta Pérez-Gómez Moreta, et al.
Publicado: (2021) -
FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer’s disease
por: Paroni G, et al.
Publicado: (2014) -
Association between human paraoxonase 2 protein and efficacy of acetylcholinesterase inhibiting drugs used against Alzheimer's disease.
por: Fauzia Parween, et al.
Publicado: (2021)